All patients | Adverse outcomes | p-value | ||
---|---|---|---|---|
(n = 845) | Yes (n = 81) | No (n = 764) | ||
Sex (male) | 420 (49.7%) | 42(51.9%) | 378 (49.5%) | 0.68 |
Age (years) | 60.05 ± 15.43 | 59.36 ± 15.74 | 60.12 ± 15.40 | 0.93 |
Heart rate (beats/min) | 86.57 ± 17.81 | 108.64 ± 22.84 | 84.23 ± 15.45 | < 0.001 |
Systolic pressure (mmHg) | 124.33 ± 18.26 | 115.22 ± 19.64 | 125.30 ± 17.85 | < 0.001 |
RV dysfunction | 240(28.4%) | 59(72.8%) | 181(23.7%) | < 0.001 |
c-Tn I (μg/L) | 0.11 ± 0.47 | 0.25 ± 0.49 | 0.091 ± 0.46 | < 0.001 |
NT-pro BNP (pg/mL) | 1,547.12 ± 3,652.06 | 131,039 ± 3,255.93 | 3,779.92 ± 5,832.71 | < 0.001 |
CPA embolism | 209 (24.7%) | 45 (55.6%) | 164 (22.0%) | < 0.001 |
Saddle-CPA embolism | 62 (7.3%) | 17 (21.0%) | 45 (5.9%) | < 0.001 |
RV short-axis diameter (mm) | 39.21 ± 7.42 | 44.70 ± 8.53 | 38.62 ± 7.05 | < 0.001 |
LV short-axis diameter (mm) | 40.76 ± 7.30 | 33.68 ± 6.91 | 41.51 ± 6.94 | < 0.001 |
RV4-chamber diameter (mm) | 36.38 ± 7.37 | 42.64 ± 10.28 | 35.72 ± 6.67 | < 0.001 |
LV 4-chamber diameter (mm) | 39.47 ± 7.36 | 31.63 ± 7.09 | 40.30 ± 6.88 | < 0.001 |
RA 4-chamber diameter (mm) | 45.44 ± 9.34 | 52.38 ± 11.72 | 44.70 ± 8.74 | < 0.001 |
LA 4-chamber diameter (mm) | 34.83 ± 8.52 | 29.18 ± 8.00 | 35.43 ± 8.35 | < 0.001 |
RV/LV short-axis diameter ratio | 1.00 ± 0.30 | 1.38 ± 0.40 | 0.96 ± 0.25 | < 0.001 |
RV/LV 4-chamber diameter ratio | 0.96 ± 0.31 | 1.44 ± 0.59 | 0.90 ± 0.20 | < 0.001 |
RA/LA 4-chamber diameter ratio | 1.39 ± 0.52 | 1.97 ± 0.87 | 1.33 ± 0.42 | < 0.001 |
Bova score | ||||
Low risk | 681 (75.9%) | 33 (40.7%) | 648 (84.4%) | < 0.001 |
Intermediate-low risk | 102 (12.1%) | 17 (20.7%) | 85 (11.1%) | 0.009 |
Intermediate-high risk | 62 (7.3%) | 31 (38.3%) | 31 (4.1%) | < 0.001 |
2019 ESC algorithm | ||||
Low risk | 503 (59.5%) | 17 (21.0%) | 486 (63.6%) | < 0.001 |
Intermediate-low risk | 172 (20.4%) | 14 (17.3%) | 158 (20.7%) | 0.47 |
Intermediate-high risk | 170 (20.1%) | 50 (61.7%) | 120 (15.7%) | < 0.001 |